Literature DB >> 12681250

Gleevec does not cross blood-brain barrier.

Kathryn Senior.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12681250     DOI： 10.1016/s1470-2045(03)01050-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  8 in total

Review 1.  Emerging treatments and gene expression profiling in high-risk medulloblastoma.

Authors:  Iacopo Sardi; Duccio Cavalieri; Maura Massimino
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 2.  RNA interference and nonviral targeted gene therapy of experimental brain cancer.

Authors:  Ruben J Boado
Journal:  NeuroRx       Date:  2005-01

3.  Three paths to better tyrosine kinase inhibition behind the blood-brain barrier in treating chronic myelogenous leukemia and glioblastoma with imatinib.

Authors:  Richard E Kast; Daniele Focosi
Journal:  Transl Oncol       Date:  2010-02       Impact factor: 4.243

4.  Report of Canonical BCR-ABL1 Fusion in Glioblastoma.

Authors:  Ying Pang; Guangyang Yu; Madison Butler; Sivasish Sindiri; Young K Song; Jun S Wei; Xinyu Wen; Hisen-Chao Chou; Martha Quezado; Svetlana Pack; Liqiang Xi; Zied Abdullaev; Olga Kim; Alice Ranjan; Mythili Merchant; Ramya Antony; Lisa Boris; Orwa Aboud; David Kamson; Rosandra Kaplan; Megan Mackey; Kevin Camphausen; Kareem Zaghloul; Terri S Armstrong; Mark R Gilbert; Kenneth Aldape; Matthias Holdhoff; Javed Khan; Jing Wu
Journal:  JCO Precis Oncol       Date:  2021-08-25

Review 5.  Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics.

Authors:  Camilla Krakstad; Martha Chekenya
Journal:  Mol Cancer       Date:  2010-06-01       Impact factor: 27.401

6.  Metastatic cerebellar gastrointestinal stromal tumor with obstructive hydrocephalus arising from the small intestine: a case report and review of the literature.

Authors:  Kunitomo Sato; Toshihide Tanaka; Naoki Kato; Takuya Ishii; Toru Terao; Yuichi Murayama
Journal:  Case Rep Oncol Med       Date:  2014-12-28

7.  Imatinib-resistant chronic myeloid leukemia (CML): Current concepts on pathogenesis and new emerging pharmacologic approaches.

Authors:  Peter Valent
Journal:  Biologics       Date:  2007-12

8.  Striking reduction of amyloid plaque burden in an Alzheimer's mouse model after chronic administration of carmustine.

Authors:  Crystal D Hayes; Debleena Dey; Juan Pablo Palavicini; Hongjie Wang; Kshitij A Patkar; Dimitriy Minond; Adel Nefzi; Madepalli K Lakshmana
Journal:  BMC Med       Date:  2013-03-26       Impact factor: 8.775
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.